Systematic review of fondaparinux for heparin-induced thrombocytopenia: When there are no randomized controlled trials

about

Systematic review of fondaparinux for heparin-induced thrombocytopenia: When there are no randomized controlled trials

Item

http://www.wikidata.org/entity/Q57824209

description

article

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Systematic review of fondapari ...... o randomized controlled trials

@en

Systematic review of fondapari ...... o randomized controlled trials

@nl

type

Item

label

Systematic review of fondapari ...... o randomized controlled trials

@en

Systematic review of fondapari ...... o randomized controlled trials

@nl

prefLabel

Systematic review of fondapari ...... o randomized controlled trials

@en

Systematic review of fondapari ...... o randomized controlled trials

@nl

P1476

Systematic review of fondapari ...... o randomized controlled trials

@en

P2093

George Hu

http://www.w3.org/2001/XMLSchema#string

Lori-Ann Linkins

http://www.w3.org/2001/XMLSchema#string

P2860

Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings.

Low-dose fondaparinux in suspected heparin-induced thrombocytopenia in the critically ill.

Fondaparinux for the treatment of patients with acute heparin-induced thrombocytopenia.

The approach to heparin-induced thrombocytopenia.

Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Treatment of heparin-induced thrombocytopenia after cardiac surgery: preliminary experience with fondaparinux.

Fondaparinux and the management of heparin-induced thrombocytopenia: the journey continues.

Fondaparinux for the treatment of acute heparin-induced thrombocytopenia: a single-center experience.

Fondaparinux: does it cause HIT? Can it treat HIT?

Prevalence and risk of preexisting heparin-induced thrombocytopenia antibodies in patients with acute VTE.

P304

678-683

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/RTH2.12145

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Theodore E Warkentin

P577

2018-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30349886

http://www.w3.org/2001/XMLSchema#string

P921

thrombocytopenia

P932

6178656

http://www.w3.org/2001/XMLSchema#string